6505--Contingency Compounded Sterile Products Service

The Department of Veterans Affairs Veterans Health Administration is seeking competitive quotes for contingency hazardous compounded sterile products services, specifically aseptically compounded chemotherapy agents for the G.V. (Sonny) Montgomery VA Medical Center in Jackson, Mississippi. This Request for Quote (RFQ) solicitation number 36C25626Q0014 is issued under simplified procedures for commercial items with NAICS code 325412 and applies to firms with a size standard of 1,300 employees. Contractors must comply with FDA 503A requirements, USP 797 and USP 800 standards, maintain appropriate certifications, and deliver compounded medications by 11:30 a.m. CST the day after order placement to support approximately 10-12 patients receiving daily infusions. Evaluation criteria include technical capability, past performance, price, and socioeconomic status, with the government utilizing a Quality Assurance Surveillance Plan that implements 100% inspection, direct observation, and validated user complaints to assess performance on an "Excellent," "Satisfactory," or "Unsatisfactory" scale. Electronic quotes are due by 10:00 a.m. Central Time on September 29, 2025, and all questions or concerns must be submitted via email to tammie.chaney@va.gov by 1:00 p.m. Central Time on September 24, 2025.

This solicitation is set aside for small businesses with preference given to Service-Disabled Veteran-Owned Small Businesses (SDVOSB) and Veteran-Owned Small Businesses (VOSB). The contract is structured as an Indefinite-Delivery-Indefinite-Quantity (IDIQ) firm-fixed-price agreement with a guaranteed minimum value of $2,500 and a maximum capacity of $4,000,000 across all ordering periods. The performance period extends for five ordering periods from the date of award through September 30, 2030, providing a five-year service contract term. Pricing is required for commonly used chemotherapeutic agents listed in the solicitation attachments, along with various dispensing fees for different compounding scenarios including chemoembolic mixing, intrathecal mixing, and STAT orders. The place of performance is 1500 E Woodrow Wilson Ave, Jackson, MS 39216, USA, where the contractor must maintain FDA 503A compliance and adhere to monthly invoicing requirements for services rendered.